Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Phase I/II Study of PDR001 in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase I/II trial update for PDR001 in advanced malignancies completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy [Phase 2]
Phase II study evaluating Abraxane plus gemcitabine in advanced adenocarcinoma non-small cell lung cancer progressing after first-line plati…
-
FDA approval · 2021-09-24FDA Approved: ALUNBRIG — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ALUNBRIG (brigatinib) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC [Phase 2]
Phase 2 trial update exploring Envafolimab as first-line treatment in aged patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC [Phase 2]
Phase 2 trial exploring toripalimab with platinum-based chemotherapy for mutation-negative stage IV oligometastatic non-small cell lung canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-09-22FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XALKORI (crizotinib) submitted by Pfizer Laboratories Div Pfizer Inc, resulting in an approved u…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Tarceva (erlotinib) with whole brain radiation therapy for brain metastases from non-sm…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest. [Phase 2]
Phase 2 clinical trial exploring immunodynamic monitoring during neoadjuvant chemotherapy immunotherapy in solid chest tumors, including non…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing BAT1706 to EU Avastin in advanced non-squamous non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma [Phase 1, Phase 2]
Phase 1/2 trial investigating genetically modified T cells for stage III-IV non-small cell lung cancer and mesothelioma; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598) [Phase 3]
Phase 3 trial of pembrolizumab with ipilimumab or placebo in untreated metastatic non-small cell lung cancer has completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC [Phase 1, Phase 2]
Preliminary safety, pharmacokinetic and efficacy signals for AC0010 in EGFR T790M–positive NSCLC from Phase 1/2 study.
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Camrelizumab Combined With Local Treatment in NSCLC Patients With BM [Phase 2]
Phase 2 trial update examining camrelizumab plus local treatment in stage IV non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy plus thalidomide in patients with stage IIIB or stage IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating chemotherapy and radiation therapy with or without epoetin alfa in stage IIIA/IIIB non-small cell lung cancer compl…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating galunisertib in combination with nivolumab for advanced solid tumors, including recurrent or refractory non-small…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium
Clinical trial update on how patient characteristics influence treatment decisions for stage IV non-small cell lung cancer in Belgium; resul…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating almonertinib in combination with microwave ablation in advanced non-small cell lung cancer is in progres…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 clinical trial of Letetresgene autoleucel engineered T cells targeting NY-ESO-1 in advanced non-small cell lung cancer has completed…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Study of Stereotactic Ablative Radiotherapy(SBRT) Followed by Atezolizumab / Tiragolumab in Treatment-naive Patients With Metastatic Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating SBRT followed by atezolizumab/tiragolumab in treatment-naive metastatic non-small cell lung cancer pati…
-
FDA approval · 2021-09-03FDA Approved: ALECENSA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Alecensa (alectinib hydrochloride) submitted by Genentech, Inc., resulting in updated labeling f…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases [Phase 2]
Phase 2 trial update on intracranial activity of AZD9291 (TAGRISSO) in advanced EGFR-mutant non-small cell lung cancer with asymptomatic bra…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC [Phase 2]
A Phase 2 clinical trial update evaluating neoadjuvant immunotherapy plus chemotherapy followed by surgery for unresectable stage III non-sm…
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy, radiation therapy, and RSR13 in stage III non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC [Phase 2]
Phase 2 trial evaluating dynamic PET/CT to assess response to neoadjuvant anti-PD1 plus chemotherapy in stage II to III non-small cell lung …